
    
      After obtaining written informed consent, patients with bilateral CTS will been randomized
      into intervention and control group. Participants in intervention group received one-dose
      ultrasound-guided hydrodissection with hyaluronic acid and control side received one-dose
      ultrasound-guided injection with normal saline. No additional treatment after injection
      through the study period. The primary outcome is Boston Carpal Tunnel Syndrome Questionnaire
      (BCTQ) and secondary outcomes include visual analog scale (VAS), cross-sectional area (CSA)
      of the median nerve, sensory nerve conduction velocity of the median nerve, and finger pinch
      strength. The evaluation was performed pretreatment as well as on the 2nd week, 1st, 3rd, 6th
      month and one year after the treatment.
    
  